Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease

Overactive bladder (OAB) is a common non-motor symptom of Parkinson disease (PD), often treated with antimuscarinics or beta-3 agonists. There is lack of evidence to guide OAB management in PD. To assess the comparative safety of antimuscarinics versus beta-3 agonists for OAB treatment in PD. We emp...

Ausführliche Beschreibung